JP2017515508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515508A5 JP2017515508A5 JP2017512646A JP2017512646A JP2017515508A5 JP 2017515508 A5 JP2017515508 A5 JP 2017515508A5 JP 2017512646 A JP2017512646 A JP 2017512646A JP 2017512646 A JP2017512646 A JP 2017512646A JP 2017515508 A5 JP2017515508 A5 JP 2017515508A5
- Authority
- JP
- Japan
- Prior art keywords
- hepatitis
- hbv
- antigen
- subject
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461994166P | 2014-05-16 | 2014-05-16 | |
| US61/994,166 | 2014-05-16 | ||
| PCT/US2015/030100 WO2015175380A1 (en) | 2014-05-16 | 2015-05-11 | VIRUS LIKE VESICLES (VLVs) BASED VACCINES TO PREVENT OR TREAT CHRONIC HEPATITIS B VIRUS (HBV) INFECTION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017515508A JP2017515508A (ja) | 2017-06-15 |
| JP2017515508A5 true JP2017515508A5 (enExample) | 2018-06-21 |
Family
ID=54480490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017512646A Pending JP2017515508A (ja) | 2014-05-16 | 2015-05-11 | 慢性ｂ型肝炎ウイルス（ｈｂｖ）感染症を予防または処置するためのウイルス様ベシクル（ｖｌｖ）ベースのワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9987353B2 (enExample) |
| EP (1) | EP3143144A4 (enExample) |
| JP (1) | JP2017515508A (enExample) |
| CN (1) | CN106459998A (enExample) |
| AU (1) | AU2015259470A1 (enExample) |
| BR (1) | BR112016026721A2 (enExample) |
| CA (1) | CA2948181A1 (enExample) |
| WO (1) | WO2015175380A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116732101A (zh) * | 2016-01-12 | 2023-09-12 | 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） | 用于治疗hbv的手段和方法 |
| EP3276006A1 (en) * | 2016-07-27 | 2018-01-31 | Theravectys | Lentiviral vectors for expression of hepatitis b virus (hbv) antigens |
| CN110382009A (zh) * | 2016-12-29 | 2019-10-25 | 富荣吉有限责任公司 | Retro-HBV和Lenti-HBV的混合载体及构建体 |
| CN108949790A (zh) * | 2017-10-27 | 2018-12-07 | 电子科技大学 | 一种基于基因工程烟草的1,2,3-三氯丙烷生物降解方法 |
| CN112513063A (zh) | 2018-05-10 | 2021-03-16 | 克莱尔博治疗有限公司 | 用于治疗乙型肝炎感染的方法和组合物 |
| EP3875470A4 (en) * | 2018-10-05 | 2023-01-18 | RNAGENE Inc. | CHIMERIC ANTIGEN WITH ENHANCED MULTI-IMMUNE FUNCTION BY SPECIFIC BINDING TO A TARGET CELL, AND USE THEREOF |
| KR20220074917A (ko) * | 2019-09-30 | 2022-06-03 | 길리애드 사이언시즈, 인코포레이티드 | Hbv 백신 및 hbv를 치료하는 방법 |
| JP2023509966A (ja) * | 2020-01-10 | 2023-03-10 | カロジェン コーポレイション | 腫瘍溶解性ウイルス様小胞の組成物および使用方法 |
| CN113138276B (zh) * | 2020-01-19 | 2022-09-16 | 厦门万泰凯瑞生物技术有限公司 | 用于检测HBcAg的方法及抗体 |
| CN113234692B (zh) * | 2021-05-11 | 2022-02-22 | 华中农业大学 | 一种包含狂犬病毒糖蛋白的感染性克隆及应用 |
| CN113736750B (zh) * | 2021-09-22 | 2023-03-31 | 中牧实业股份有限公司 | 一株盖他病毒毒株及其应用 |
| JP2025504364A (ja) * | 2022-01-08 | 2025-02-12 | カロジェン コーポレイション | 慢性ｂ型肝炎感染症を処置または防止するための複数抗原治療ワクチン |
| EP4465999A4 (en) * | 2022-02-22 | 2025-12-24 | Carogen Corp | Polyvalent Virus Vesicle (VLV) Platform for Infectious Diseases and Cancer Immunotherapy Applications |
| CN115747174B (zh) * | 2022-09-15 | 2026-02-03 | 武汉大学 | 重组溶瘤病毒rVSVM51R-C在乙肝性肝癌中的应用 |
| CN120187451A (zh) * | 2022-11-07 | 2025-06-20 | 厦门大学 | 一种融合蛋白以及包含其的颗粒化的抗原 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009090594A2 (en) | 2008-01-11 | 2009-07-23 | Yale University | Alphavirus based vectors |
| US20030099932A1 (en) | 1998-05-12 | 2003-05-29 | Lorens James B. | Retroviral vectors with separation sequences |
| ES2170622B1 (es) * | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
| JP2009511636A (ja) * | 2005-10-18 | 2009-03-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | アルファウイルスレプリコン粒子による粘膜免疫および全身免疫 |
| JP2017515509A (ja) | 2014-05-16 | 2017-06-15 | イエール ユニバーシティ | ワクチン用途のための高力価ウイルス様ベシクルの進化の方法 |
-
2015
- 2015-05-11 CN CN201580025501.8A patent/CN106459998A/zh active Pending
- 2015-05-11 JP JP2017512646A patent/JP2017515508A/ja active Pending
- 2015-05-11 WO PCT/US2015/030100 patent/WO2015175380A1/en not_active Ceased
- 2015-05-11 CA CA2948181A patent/CA2948181A1/en not_active Abandoned
- 2015-05-11 EP EP15793197.3A patent/EP3143144A4/en not_active Withdrawn
- 2015-05-11 BR BR112016026721A patent/BR112016026721A2/pt not_active IP Right Cessation
- 2015-05-11 US US15/305,180 patent/US9987353B2/en active Active
- 2015-05-11 AU AU2015259470A patent/AU2015259470A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515508A5 (enExample) | ||
| US9987353B2 (en) | Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection | |
| JP2019526580A5 (enExample) | ||
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| Zhang et al. | Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71 | |
| Wang et al. | Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice | |
| JP6259831B2 (ja) | Ｃ型肝炎ウイルスに対するキメラワクチン抗原 | |
| US8691234B2 (en) | Vaccine formulation potentiated by the combination of DNA and an antigen | |
| CN103757032B (zh) | 一种以流感病毒为载体的hcv嵌合疫苗及其制备方法 | |
| Davis | DNA-based immunization against hepatitis B: experience with animal models | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| WO2005056051A2 (en) | Hepatitis b vaccines and compositions | |
| Zhou et al. | Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine | |
| JP2025504364A (ja) | 慢性ｂ型肝炎感染症を処置または防止するための複数抗原治療ワクチン | |
| US20100322965A1 (en) | Viral vaccine vectors | |
| Edwards et al. | Developing mucosal vaccines for SARS-cov-2: What will it take? | |
| pertussis Novavax et al. | Covid-19 Vaccines: Several technologies at work | |
| De Ganzó et al. | Virus-Like Particles: Applications in Reverse Vaccinology | |
| RU2353651C2 (ru) | Рекомбинантные векторы на основе "живого" вируса оспы домашней птицы и их применение в фармацевтических композициях против вируса гепатита с | |
| HILLEMAN | Merck Institute for Therapeutic Research, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486, USA | |
| JP2008508890A6 (ja) | 組換え生鶏痘ウィルスベクター及びｃ型肝炎ウィルスに対する薬剤組成物中でのそれらの使用 | |
| Camus | Development and characterization of Lassa virus vaccines and mouse model |